Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1.
Wu W, Nelson GM, Koch R, Donovan KA, Nowak RP, Heavican-Foral TB, Nirmal AJ, Liu H, Yang L, Duffy J, Powers F, Stevenson KE, Jones MK, Ng SY, Wu G, Jain S, Xu R, Amaka S, Trevisani C, Donaldson NL, Hagner PR, de Leval L, Gaulard P, Iqbal J, Thakurta A, Fischer ES, Adelman K, Weinstock DM. Wu W, et al. Among authors: gaulard p. Blood. 2022 Mar 31;139(13):2024-2037. doi: 10.1182/blood.2021014701. Blood. 2022. PMID: 34936696 Free PMC article.
Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland ML, Le Gouvello S, Gaulard P, Leroy K, Castellano F. Guiter C, et al. Among authors: gaulard p. Blood. 2004 Jul 15;104(2):543-9. doi: 10.1182/blood-2003-10-3545. Epub 2004 Mar 25. Blood. 2004. PMID: 15044251 Free article.
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
Bossard C, Belhadj K, Reyes F, Martin-Garcia N, Berger F, Kummer JA, Brière J, Baglin AC, Cheze S, Bosq J, Ribrag V, Gisselbrecht C, Mounier N, Gaulard P. Bossard C, et al. Among authors: gaulard p. Blood. 2007 Mar 1;109(5):2183-9. doi: 10.1182/blood-2006-07-033142. Epub 2006 Oct 31. Blood. 2007. PMID: 17077322 Free article. Clinical Trial.
The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.
de Leval L, Rickman DS, Thielen C, Reynies Ad, Huang YL, Delsol G, Lamant L, Leroy K, Brière J, Molina T, Berger F, Gisselbrecht C, Xerri L, Gaulard P. de Leval L, et al. Among authors: gaulard p. Blood. 2007 Jun 1;109(11):4952-63. doi: 10.1182/blood-2006-10-055145. Epub 2007 Feb 6. Blood. 2007. PMID: 17284527 Free article.
Molecular classification of T-cell lymphomas.
de Leval L, Bisig B, Thielen C, Boniver J, Gaulard P. de Leval L, et al. Among authors: gaulard p. Crit Rev Oncol Hematol. 2009 Nov;72(2):125-43. doi: 10.1016/j.critrevonc.2009.01.002. Epub 2009 Feb 23. Crit Rev Oncol Hematol. 2009. PMID: 19233683 Review.
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.
Huang Y, de Reyniès A, de Leval L, Ghazi B, Martin-Garcia N, Travert M, Bosq J, Brière J, Petit B, Thomas E, Coppo P, Marafioti T, Emile JF, Delfau-Larue MH, Schmitt C, Gaulard P. Huang Y, et al. Among authors: gaulard p. Blood. 2010 Feb 11;115(6):1226-37. doi: 10.1182/blood-2009-05-221275. Epub 2009 Nov 30. Blood. 2010. PMID: 19965620 Free PMC article.
CD30+ lymphoproliferative disorders.
de Leval L, Gaulard P. de Leval L, et al. Among authors: gaulard p. Haematologica. 2010 Oct;95(10):1627-30. doi: 10.3324/haematol.2010.029256. Haematologica. 2010. PMID: 20884717 Free PMC article. No abstract available.
Pathology and biology of peripheral T-cell lymphomas.
de Leval L, Gaulard P. de Leval L, et al. Among authors: gaulard p. Histopathology. 2011 Jan;58(1):49-68. doi: 10.1111/j.1365-2559.2010.03704.x. Histopathology. 2011. PMID: 21261683 Review.
435 results